Prevalence of icaA and icaD genes in Staphylococcus aureus and Staphylococcus epidermidis strains isolated from patients and hospital staff
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17645225
DOI
10.21101/cejph.a3396
Knihovny.cz E-resources
- MeSH
- Biofilms * MeSH
- Congo Red metabolism MeSH
- Culture Media MeSH
- Humans MeSH
- Cell Adhesion Molecules analysis genetics MeSH
- Patients * MeSH
- Personnel, Hospital * MeSH
- Polymerase Chain Reaction MeSH
- Base Sequence MeSH
- Staphylococcal Infections microbiology MeSH
- Staphylococcus aureus genetics physiology MeSH
- Staphylococcus epidermidis genetics physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Congo Red MeSH
- Culture Media MeSH
- Cell Adhesion Molecules MeSH
Staphylococci are ubiquitous microorganisms that predominate in normal skin and mucosal flora. Staphylococcus aureus and Staphylococcus epidermidis have been identified as a major cause of nosocomial infections, especially in patients with predisposing factors such as indwelling or implanted foreign bodies. The ability of both S. epidermidis and S. aureus to produce biofilm was compared between 116 clinically significant strains (46 from blood cultures of patients with bloodstream infection and 70 isolated from catheters) and 60 strains isolated from nasal swabs of healthy carriers from hospital staff. The presence of the intercellular adhesion genes (icaA and icaD) was determined by the Polymerase Chain Reaction method, and slime production was examined using qualitative Congo red agar technique. Among clinical strains, 35.2% (19/54) of S. aureus and 48.4% (30/62) of S.epidermidis were both positive icaA and icaD and they produced slime. Among carrier strains, 22.2% (8/36) of S. aureus and 33.3% (8/24) of S. epidermidis were positive for slime synthesis and exhibited ica genes. Our results suggest that the virulence factors contributing to the development of infections can be present in patient and hospital staff isolates. Thus, we consider it is important to detect healthy carriers of slime-producing staphylococci and to control the dissemination of these microorganisms especially in a hospital.
See more in PubMed
Nervenarzt. 2004 Dec;75(12):1187-93 PubMed
Health Soc Care Community. 2004 Sep;12(5):414-21 PubMed
Soc Sci Med. 1998 Sep;47(5):565-79 PubMed
Health Aff (Millwood). 2005 Jul-Dec;Suppl Web Exclusives:W5-509-25 PubMed
Palliat Med. 2000 Mar;14(2):93-104 PubMed
Palliat Med. 2005 Mar;19(2):119-27 PubMed
Semin Oncol Nurs. 2005 Feb;21(1):69-73 PubMed
Int J Palliat Nurs. 2001 May;7(5):221-6 PubMed
Nurs Clin North Am. 2001 Dec;36(4):843-53, ix PubMed
Soc Sci Med. 1999 May;48(9):1271-80 PubMed
Praxis (Bern 1994). 1999 Jul 22;88(29-30):1224-8 PubMed
BMJ. 2002 Nov 30;325(7375):1263 PubMed
Support Care Cancer. 2003 Jul;11(7):442-51 PubMed
Eur J Cancer Care (Engl). 2003 Dec;12(4):331-8 PubMed
Eval Health Prof. 2007 Mar;30(1):96-109 PubMed
J Palliat Med. 2005 Jun;8(3):486-9 PubMed
